Encompass Health Co. (NYSE:EHC) Stock Holdings Increased by Invesco Ltd.

Invesco Ltd. grew its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,536,251 shares of the company's stock after acquiring an additional 176,135 shares during the period. Invesco Ltd. owned about 5.50% of Encompass Health worth $511,273,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Encompass Health by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock valued at $960,817,000 after buying an additional 138,196 shares during the last quarter. State Street Corp increased its position in Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock valued at $292,410,000 after acquiring an additional 21,329 shares during the last quarter. Alliancebernstein L.P. raised its position in Encompass Health by 6.0% in the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock worth $191,799,000 after purchasing an additional 117,617 shares during the period. FMR LLC lifted its stake in shares of Encompass Health by 0.8% during the 4th quarter. FMR LLC now owns 1,973,846 shares of the company's stock worth $182,285,000 after acquiring an additional 15,831 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Encompass Health by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock worth $155,176,000 after purchasing an additional 6,164 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Remove Ads

Encompass Health Stock Up 1.3 %

EHC stock traded up $1.33 during midday trading on Monday, reaching $103.50. 231,788 shares of the company were exchanged, compared to its average volume of 659,330. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $104.62. The company has a market cap of $10.42 billion, a price-to-earnings ratio of 23.21, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The stock's 50-day simple moving average is $99.56 and its 200 day simple moving average is $98.03.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Insider Buying and Selling at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 2.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on EHC. StockNews.com downgraded Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday, April 3rd. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Barclays lifted their price target on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.